{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:25:05Z","timestamp":1780082705318,"version":"3.54.0"},"reference-count":144,"publisher":"Bentham Science Publishers Ltd.","issue":"27","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia and joint damage. Systemic complications and progressive disability are burdens that lead to a significant socio-economic costs in patients with RA. Current RA biomarkers used in predicting, diagnosing, and monitoring the treatment of the disease have not been very successful. Moreover, only 60% of patients show a satisfactory response to current biological and conventional therapies. Studies on immunometabolism have suggested that dysregulated enzymes, transcription factors, metabolites, and metabolic pathways could be considered potential therapeutic targets for the treatment of RA. Factors such as the high concentration of various intermediate molecules arising from metabolism, hypoxia, lack of nutrients, and other metabolic alterations affect local immune responses and preserve a state of chronic inflammation in synovial tissues. Fortunately, in vitro and in vivo studies have shown that targeting specific metabolic pathways is associated with a decreased level of inflammation. Specifically, targeting metabolic intermediates, such as succinate or lactate, has shown promising clinical outcomes in RA treatment. These findings open an avenue for the identification of novel biomarkers for diagnosis, prognosis, and determining the success of various treatments in RA patients, as well as the discovery of new therapeutic targets.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867329666220907151213","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:19:20Z","timestamp":1662722360000},"page":"3119-3136","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Immunometabolism Dysfunction in the Pathophysiology and Treatment of Rheumatoid Arthritis"],"prefix":"10.2174","volume":"30","author":[{"given":"Maryam","family":"Masoumi","sequence":"first","affiliation":[{"name":"Clinical Research Development Center, Shahid Beheshti Hospital, Qom University of Medical Sciences, Qom, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Moadab","sequence":"additional","affiliation":[{"name":"Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"},{"name":"Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"},{"name":"Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Didehdar","sequence":"additional","affiliation":[{"name":"Department of Medical Parasitology and Mycology, Arak University of Medical Sciences, Arak, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Farahani","sequence":"additional","affiliation":[{"name":"Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[{"name":"Molecular Medicine Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"},{"name":"Department of Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran"},{"name":"Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Department of Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar","family":"Karami","sequence":"additional","affiliation":[{"name":"Department of Laboratory Sciences, Khomein University of Medical Sciences, Khomein, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"119034","DOI":"10.1016\/j.lfs.2021.119034","volume":"269","author":"Moadab F.","year":"2021","unstructured":"Moadab F.; Khorramdelazad H.; Abbasifard M.; Role of CCL2\/CCR2 axis in the \"immunopathogenesis\" of rheumatoid arthritis: Latest evidence and therapeutic approaches. Life Sci 2021,269,119034","journal-title":"Life Sci"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/imcb.12311","volume":"98","author":"Karami J.","year":"2020","unstructured":"Karami J.; Aslani S.; Tahmasebi M.N.; Mousavi M.J.; Sharafat Vaziri A.; Jamshidi A.; Farhadi E.; Mahmoudi M.; Epigenetics in rheumatoid arthritis; fibroblast\u2010like synoviocytes as an emerging paradigm in the pathogenesis of the disease. Immunol Cell Biol 2020,98(3),171-186","journal-title":"Immunol Cell Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"R90","DOI":"10.1186\/ar4555","volume":"16","author":"Dennis G.","year":"2014","unstructured":"Dennis G.; Holweg C.T.J.; Kummerfeld S.K.; Choy D.F.; Setiadi A.F.; Hackney J.A.; Haverty P.M.; Gilbert H.; Lin W.Y.; Diehl L.; Fischer S.; Song A.; Musselman D.; Klearman M.; Gabay C.; Kavanaugh A.; Endres J.; Fox D.A.; Martin F.; Townsend M.J.; Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res Ther 2014,16(2),R90","journal-title":"Arthritis Res Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"McInnes I.B.","year":"2011","unstructured":"McInnes I.B.; Schett G.; The pathogenesis of rheumatoid arthritis. N Engl J Med 2011,365(23),2205-2219","journal-title":"N Engl J Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1136\/annrheumdis-2018-214539","volume":"78","author":"Humby F.","year":"2019","unstructured":"Humby F.; Lewis M.; Ramamoorthi N.; Hackney J.A.; Barnes M.R.; Bombardieri M.; Setiadi A.F.; Kelly S.; Bene F.; DiCicco M.; Riahi S.; Rocher V.; Ng N.; Lazarou I.; Hands R.; van der Heijde D.; Landew\u00e9 R.B.M.; van der Helm-van Mil A.; Cauli A.; McInnes I.; Buckley C.D.; Choy E.H.; Taylor P.C.; Townsend M.J.; Pitzalis C.; Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients. Ann Rheum Dis 2019,78(6),761-772","journal-title":"Ann Rheum Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/annrheumdis-2021-220043","volume":"80","author":"Meehan G.R.","year":"2021","unstructured":"Meehan G.R.; Thomas R.; Al Khabouri S.; Wehr P.; Hilkens C.M.U.; Wraith D.C.; Sieghart D.; Bonelli M.; Nagy G.; Garside P.; Tough D.F.; Lewis H.D.; Brewer J.M.; Preclinical models of arthritis for studying immunotherapy and immune tolerance. Ann Rheum Dis 2021,80(10),1268-1277","journal-title":"Ann Rheum Dis"},{"key":"ref=7","first-page":"30173","author":"Smolen J.","year":"2016","unstructured":"Smolen J.; Aletaha D.; McInnes I.; Therapies for bone R. Lancet 2016,30173-30178","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"Croft A.P.","year":"2019","unstructured":"Croft A.P.; Campos J.; Jansen K.; Turner J.D.; Marshall J.; Attar M.; Savary L.; Wehmeyer C.; Naylor A.J.; Kemble S.; Begum J.; D\u00fcrholz K.; Perlman H.; Barone F.; McGettrick H.M.; Fearon D.T.; Wei K.; Raychaudhuri S.; Korsunsky I.; Brenner M.B.; Coles M.; Sansom S.N.; Filer A.; Buckley C.D.; Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 2019,570(7760),246-251","journal-title":"Nature"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI106594","volume":"50","author":"Goetzi E.J.","year":"1971","unstructured":"Goetzi E.J.; Falchuk K.H.; Zeiger L.S.; Sullivan A.L.; Hebert C.L.; Adams J.P.; Decker J.L.; A physiological approach to the assessment of disease activity in rheumatoid arthritis. J Clin Invest 1971,50(6),1167-1180","journal-title":"J Clin Invest"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/art.1780140407","volume":"14","author":"Treuhaft P.S.","year":"1971","unstructured":"Treuhaft P.S.; McCarty D.J.; Synovial fluid pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum 1971,14(4),475-484","journal-title":"Arthritis Rheum"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1074\/mcp.M114.045575","volume":"14","author":"Patella F.","year":"2015","unstructured":"Patella F.; Schug Z.T.; Persi E.; Neilson L.J.; Erami Z.; Avanzato D.; Maione F.; Hernandez-Fernaud J.R.; Mackay G.; Zheng L.; Reid S.; Frezza C.; Giraudo E.; Fiorio Pla A.; Anderson K.; Ruppin E.; Gottlieb E.; Zanivan S.; Proteomics-based metabolic modeling reveals that fatty acid oxidation (FAO) controls endothelial cell (EC) permeability. Mol Cell Proteomics 2015,14(3),621-634","journal-title":"Mol Cell Proteomics"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"Smolen J.S.","year":"2016","unstructured":"Smolen J.S.; Breedveld F.C.; Burmester G.R.; Bykerk V.; Dougados M.; Emery P.; Kvien T.K.; Navarro-Comp\u00e1n M.V.; Oliver S.; Schoels M.; Scholte-Voshaar M.; Stamm T.; Stoffer M.; Takeuchi T.; Aletaha D.; Andreu J.L.; Aringer M.; Bergman M.; Betteridge N.; Bijlsma H.; Burkhardt H.; Cardiel M.; Combe B.; Durez P.; Fonseca J.E.; Gibofsky A.; Gomez-Reino J.J.; Graninger W.; Hannonen P.; Haraoui B.; Kouloumas M.; Landewe R.; Martin-Mola E.; Nash P.; Ostergaard M.; \u00d6st\u00f6r A.; Richards P.; Sokka-Isler T.; Thorne C.; Tzioufas A.G.; van Vollenhoven R.; de Wit M.; van der Heijde D.; Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016,75(1),3-15","journal-title":"Ann Rheum Dis"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"331fs8","DOI":"10.1126\/scitranslmed.aaf4953","volume":"8","author":"Tsokos GC","year":"2016","unstructured":"Tsokos GC; Metabolic control of arthritis: Switch pathways to treat. Sci Transl Med 2016,8(331),331fs8","journal-title":"Sci Transl Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"331ra38","DOI":"10.1126\/scitranslmed.aad7151","volume":"8","author":"Yang Z.","year":"2016","unstructured":"Yang Z.; Shen Y.; Oishi H.; Matteson E.L.; Tian L.; Goronzy J.J.; Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med 2016,8(331),331ra38","journal-title":"Sci Transl Med"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jpba.2016.02.004","volume":"127","author":"Zhou J.","year":"2016","unstructured":"Zhou J.; Chen J.; Hu C.; Xie Z.; Li H.; Wei S.; Wang D.; Wen C.; Xu G.; Exploration of the serum metabolite signature in patients with rheumatoid arthritis using gas chromatography\u2013mass spectrometry. J Pharm Biomed Anal 2016,127,60-67","journal-title":"J Pharm Biomed Anal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13317-020-00135-z","volume":"11","author":"Nejatbakhsh Samimi L.","year":"2020","unstructured":"Nejatbakhsh Samimi L.; Farhadi E.; Tahmasebi M.N.; Jamshidi A.; Sharafat Vaziri A.; Mahmoudi M.; NF-\u03baB signaling in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Auto Immun Highlights 2020,11(1),11","journal-title":"Auto Immun Highlights"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/ITT.S288547","volume":"10","author":"Unterberger S.","year":"2021","unstructured":"Unterberger S.; Davies K.A.; Rambhatla S.B.; Sacre S.; Contribution of toll-like receptors and the NLRP3 inflammasome in rheumatoid arthritis pathophysiology. ImmunoTargets Ther 2021,10,285-298","journal-title":"ImmunoTargets Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/art.38021","volume":"65","author":"Young S.P.","year":"2013","unstructured":"Young S.P.; Kapoor S.R.; Viant M.R.; Byrne J.J.; Filer A.; Buckley C.D.; Kitas G.D.; Raza K.; The impact of inflammation on metabolomic profiles in patients with arthritis. Arthritis Rheum 2013,65(8),2015-2023","journal-title":"Arthritis Rheum"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.1021\/pr1002774","volume":"9","author":"Lauridsen M.B.","year":"2010","unstructured":"Lauridsen M.B.; Bliddal H.; Christensen R.; Danneskiold-Sams\u00f8e B.; Bennett R.; Keun H.; Lindon J.C.; Nicholson J.K.; Dorff M.H.; Jaroszewski J.W.; Hansen S.H.; Cornett C.; 1H NMR spectroscopy-based interventional metabolic phenotyping: A cohort study of rheumatoid arthritis patients. J Proteome Res 2010,9(9),4545-4553","journal-title":"J Proteome Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s10067-018-4021-6","volume":"37","author":"Li J.","year":"2018","unstructured":"Li J.; Che N.; Xu L.; Zhang Q.; Wang Q.; Tan W.; Zhang M.; LC-MS-based serum metabolomics reveals a distinctive signature in patients with rheumatoid arthritis. Clin Rheumatol 2018,37(6),1493-1502","journal-title":"Clin Rheumatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3390\/ijms17101757","volume":"17","author":"Guo H.","year":"2016","unstructured":"Guo H.; Niu X.; Gu Y.; Lu C.; Xiao C.; Yue K.; Zhang G.; Pan X.; Jiang M.; Tan Y.; Kong H.; Liu Z.; Xu G.; Lu A.; Differential amino acid, carbohydrate and lipid metabolism perpetuations involved in a subtype of rheumatoid arthritis with chinese medicine cold pattern. Int J Mol Sci 2016,17(10),1757","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jpba.2015.10.007","volume":"117","author":"Zabek A.","year":"2016","unstructured":"Zabek A.; Swierkot J.; Malak A.; Zawadzka I.; Deja S.; Bogunia-Kubik K.; Mlynarz P.; Application of 1 H NMR-based serum metabolomic studies for monitoring female patients with rheumatoid arthritis. J Pharm Biomed Anal 2016,117,544-550","journal-title":"J Pharm Biomed Anal"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e0132695","DOI":"10.1371\/journal.pone.0132695","volume":"10","author":"Yang X.Y.","year":"2015","unstructured":"Yang X.Y.; Zheng K.D.; Lin K.; Zheng G.; Zou H.; Wang J.M.; Lin Y.Y.; Chuka C.M.; Ge R.S.; Zhai W.; Wang J.G.; Energy metabolism disorder as a contributing factor of rheumatoid arthritis: A comparative proteomic and metabolomic study. PLoS One 2015,10(7),e0132695","journal-title":"PLoS One"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar3243","volume":"13","author":"Madsen R.K.","year":"2011","unstructured":"Madsen R.K.; Lundstedt T.; Gabrielsson J.; Sennbro C.J.; Alenius G.M.; Moritz T.; Rantap\u00e4\u00e4-Dahlqvist S.; Trygg J.; Diagnostic properties of metabolic perturbations in rheumatoid arthritis. Arthritis Res Ther 2011,13(1),R19","journal-title":"Arthritis Res Ther"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coi.2017.04.010","volume":"46","author":"Weyand C.M.","year":"2017","unstructured":"Weyand C.M.; Zeisbrich M.; Goronzy J.J.; Metabolic signatures of T-cells and macrophages in rheumatoid arthritis. Curr Opin Immunol 2017,46,112-120","journal-title":"Curr Opin Immunol"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cmet.2019.10.004","volume":"30","author":"Pucino V","year":"2019","unstructured":"Pucino V; Certo M; Bulusu V; Cucchi D; Goldmann K; Pontarini E; Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4+ T cell metabolic rewiring. Cell metabolism 2019,30(6),1055-74","journal-title":"Cell metabolism"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1084\/jem.20130252","volume":"210","author":"Yang Z.","year":"2013","unstructured":"Yang Z.; Fujii H.; Mohan S.V.; Goronzy J.J.; Weyand C.M.; Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med 2013,210(10),2119-2134","journal-title":"J Exp Med"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1136\/annrheumdis-2015-208476","volume":"75","author":"Biniecka M.","year":"2016","unstructured":"Biniecka M.; Canavan M.; McGarry T.; Gao W.; McCormick J.; Cregan S.; Gallagher L.; Smith T.; Phelan J.J.; Ryan J.; O\u2019Sullivan J.; Ng C.T.; Veale D.J.; Fearon U.; Dysregulated bioenergetics: A key regulator of joint inflammation. Ann Rheum Dis 2016,75(12),2192-2200","journal-title":"Ann Rheum Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/1389203716666150630135720","volume":"16","author":"Chen J.","year":"2015","unstructured":"Chen J.; Li Y.; Tian Y.; Huang C.; Li D.; Zhong Q.; Ma X.; Interaction between microbes and host intestinal health: Modulation by dietary nutrients and gut-brain-endocrine-immune axis. Curr Protein Pept Sci 2015,16(7),592-603","journal-title":"Curr Protein Pept Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41590-018-0296-7","volume":"20","author":"Wen Z.","year":"2019","unstructured":"Wen Z.; Jin K.; Shen Y.; Yang Z.; Li Y.; Wu B.; Tian L.; Shoor S.; Roche N.E.; Goronzy J.J.; Weyand C.M.; N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation. Nat Immunol 2019,20(3),313-325","journal-title":"Nat Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.metabol.2014.06.010","volume":"63","author":"Cassano S.","year":"2014","unstructured":"Cassano S.; Pucino V.; La Rocca C.; Procaccini C.; De Rosa V.; Marone G.; Matarese G.; Leptin modulates autophagy in human CD4+CD25\u2212 conventional T cells. Metabolism 2014,63(10),1272-1279","journal-title":"Metabolism"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/art.40504","volume":"70","author":"Falconer J.","year":"2018","unstructured":"Falconer J.; Murphy A.N.; Young S.P.; Clark A.R.; Tiziani S.; Guma M.; Buckley C.D.; Synovial cell metabolism and chronic inflammation in rheumatoid arthritis. Arthritis Rheumatol 2018,70(7),984-999","journal-title":"Arthritis Rheumatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.24763","volume":"60","author":"DeLay M.L.","year":"2009","unstructured":"DeLay M.L.; Turner M.J.; Klenk E.I.; Smith J.A.; Sowders D.P.; Colbert R.A.; HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009,60(9),2633-2643","journal-title":"Arthritis Rheum"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.intimp.2020.107064","volume":"89","author":"Masoumi M.","year":"2020","unstructured":"Masoumi M.; Mehrabzadeh M.; Mahmoudzehi S.; Mousavi M.J.; Jamalzehi S.; Sahebkar A.; Karami J.; Role of glucose metabolism in aggressive phenotype of fibroblast-like synoviocytes: Latest evidence and therapeutic approaches in rheumatoid arthritis. Int Immuno- pharmacol 2020,89(Pt A),107064","journal-title":"Int Immuno- pharmacol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1136\/annrheumdis-2014-207210","volume":"75","author":"Yarwood A.","year":"2016","unstructured":"Yarwood A.; Viatte S.; Okada Y.; Plenge R.; Yamamoto K.; Barton A.; Symmons D.; Raychaudhuri S.; Klareskog L.; Gregersen P.; Worthington J.; Eyre S.; Loci associated with N-glycosylation of human IgG are not associated with rheumatoid arthritis: A Mendelian randomisation study. Ann Rheum Dis 2016,75(1),317-320","journal-title":"Ann Rheum Dis"},{"key":"ref=36","first-page":"1","author":"Masoumi M.","year":"2020","unstructured":"Masoumi M.; Bashiri H.; Khorramdelazad H.; Barzaman K.; Hashemi N.; Sereshki H.A.; Destructive roles of fibroblast-like synoviocytes in chronic inflammation and joint damage in rheumatoid arthritis. Inflammation 2020,1-14","journal-title":"Inflammation"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"42412","DOI":"10.1038\/srep42412","volume":"7","author":"Okano T.","year":"2017","unstructured":"Okano T.; Saegusa J.; Nishimura K.; Takahashi S.; Sendo S.; Ueda Y.; Morinobu A.; 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17\/Treg cell differentiation and suppressing dendritic cell activation. Sci Rep 2017,7(1),42412","journal-title":"Sci Rep"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1080\/15548627.2015.1042195","volume":"11","author":"Tan V.P.","year":"2015","unstructured":"Tan V.P.; Miyamoto S.; HK2\/hexokinase-II integrates glycolysis and autophagy to confer cellular protection. Autophagy 2015,11(6),963-964","journal-title":"Autophagy"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13317-020-00145-x","volume":"12","author":"Mousavi M.J.","year":"2021","unstructured":"Mousavi M.J.; Karami J.; Aslani S.; Tahmasebi M.N.; Vaziri A.S.; Jamshidi A.; Farhadi E.; Mahmoudi M.; Transformation of fibroblast-like synoviocytes in rheumatoid arthritis; from a friend to foe. Auto Immun Highlights 2021,12(1),3","journal-title":"Auto Immun Highlights"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1002\/art.38822","volume":"66","author":"Biniecka M.","year":"2014","unstructured":"Biniecka M.; Connolly M.; Gao W.; Ng C.T.; Balogh E.; Gogarty M.; Santos L.; Murphy E.; Brayden D.; Veale D.J.; Fearon U.; Redox-mediated angiogenesis in the hypoxic joint of inflammatory arthritis. Arthritis Rheumatol 2014,66(12),3300-3310","journal-title":"Arthritis Rheumatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.autrev.2019.102397","volume":"18","author":"Tardito S.","year":"2019","unstructured":"Tardito S.; Martinelli G.; Soldano S.; Paolino S.; Pacini G.; Patane M.; Alessandri E.; Smith V.; Cutolo M.; Macrophage M1\/M2 polarization and rheumatoid arthritis: A systematic review. Autoimmun Rev 2019,18(11),102397","journal-title":"Autoimmun Rev"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4049\/jimmunol.1102073","volume":"189","author":"Bae S.","year":"2012","unstructured":"Bae S.; Kim H.; Lee N.; Won C.; Kim H.R.; Hwang Y.; Song Y.W.; Kang J.S.; Lee W.J.; \u03b1-Enolase expressed on the surfaces of monocytes and macrophages induces robust synovial inflammation in rheumatoid arthritis. J Immunol 2012,189(1),365-372","journal-title":"J Immunol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.celrep.2015.05.046","volume":"12","author":"Moon J.S.","year":"2015","unstructured":"Moon J.S.; Hisata S.; Park M.A.; DeNicola G.M.; Ryter S.W.; Nakahira K.; Choi A.M.K.; mTORC1-induced HK1-dependent glycolysis regulates NLRP3 inflammasome activation. Cell Rep 2015,12(1),102-115","journal-title":"Cell Rep"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni.3269","volume":"16","author":"De Rosa V.","year":"2015","unstructured":"De Rosa V.; Galgani M.; Porcellini A.; Colamatteo A.; Santopaolo M.; Zuchegna C.; Romano A.; De Simone S.; Procaccini C.; La Rocca C.; Carrieri P.B.; Maniscalco G.T.; Salvetti M.; Buscarinu M.C.; Franzese A.; Mozzillo E.; La Cava A.; Matarese G.; Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants. Nat Immunol 2015,16(11),1174-1184","journal-title":"Nat Immunol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.tibs.2016.05.013","volume":"41","author":"Boukouris A.E.","year":"2016","unstructured":"Boukouris A.E.; Zervopoulos S.D.; Michelakis E.D.; Metabolic enzymes moonlighting in the nucleus: Metabolic regulation of gene transcription. Trends Biochem Sci 2016,41(8),712-730","journal-title":"Trends Biochem Sci"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1084\/jem.20150900","volume":"213","author":"Shirai T.","year":"2016","unstructured":"Shirai T.; Nazarewicz R.R.; Wallis B.B.; Yanes R.E.; Watanabe R.; Hilhorst M.; Tian L.; Harrison D.G.; Giacomini J.C.; Assimes T.L.; Goronzy J.J.; Weyand C.M.; The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J Exp Med 2016,213(3),337-354","journal-title":"J Exp Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"40274","DOI":"10.1038\/srep40274","volume":"7","author":"Lu Y.","year":"2017","unstructured":"Lu Y.; Yu S.S.; Zong M.; Fan S.S.; Lu T.B.; Gong R.H.; Sun L.S.; Fan L.Y.; Glucose-6-phosphate isomerase (G6PI) mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Sci Rep 2017,7(1),40274","journal-title":"Sci Rep"},{"key":"ref=48","first-page":"195","volume":"36","author":"Thomas D.P.","year":"1955","unstructured":"Thomas D.P.; Dingle J.T.; In vitro studies of rheumatoid synovium; preliminary metabolic comparison between synovial membrane and villi. Br J Exp Pathol 1955,36(2),195-198","journal-title":"Br J Exp Pathol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"Bartok B.","year":"2010","unstructured":"Bartok B.; Firestein G.S.; Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol Rev 2010,233(1),233-255","journal-title":"Immunol Rev"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1002\/art.39270","volume":"67","author":"Fujii W.","year":"2015","unstructured":"Fujii W.; Kawahito Y.; Nagahara H.; Kukida Y.; Seno T.; Yamamoto A.; Kohno M.; Oda R.; Taniguchi D.; Fujiwara H.; Ejima A.; Kishida T.; Mazda O.; Ashihara E.; Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis. Arthritis Rheumatol 2015,67(11),2888-2896","journal-title":"Arthritis Rheumatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.intimp.2015.08.044","volume":"29","author":"Zhou R.","year":"2015","unstructured":"Zhou R.; Wu X.; Wang Z.; Ge J.; Chen F.; Interleukin-6 enhances acid-induced apoptosis via upregulating acid-sensing ion channel 1a expression and function in rat articular chondrocytes. Int Immunopharmacol 2015,29(2),748-760","journal-title":"Int Immunopharmacol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"15171","DOI":"10.1038\/srep15171","volume":"5","author":"Veras F.P.","year":"2015","unstructured":"Veras F.P.; Peres R.S.; Saraiva A.L.L.; Pinto L.G.; Louzada-Junior P.; Cunha T.M.; Paschoal J.A.R.; Cunha F.Q.; Alves-Filho J.C.; Fructose 1,6-bisphosphate, a high-energy intermediate of glycolysis, attenuates experimental arthritis by activating anti-inflammatory adenosinergic pathway. Sci Rep 2015,5(1),15171","journal-title":"Sci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.tibs.2016.02.003","volume":"41","author":"Haas R.","year":"2016","unstructured":"Haas R.; Cucchi D.; Smith J.; Pucino V.; Macdougall C.E.; Mauro C.; Intermediates of metabolism: From bystanders to signalling molecules. Trends Biochem Sci 2016,41(5),460-471","journal-title":"Trends Biochem Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13075-018-1655-3","volume":"20","author":"Narasimhan R.","year":"2018","unstructured":"Narasimhan R.; Coras R.; Rosenthal S.B.; Sweeney S.R.; Lodi A.; Tiziani S.; Boyle D.; Kavanaugh A.; Guma M.; Serum metabolomic profiling predicts synovial gene expression in rheumatoid arthritis. Arthritis Res Ther 2018,20(1),164","journal-title":"Arthritis Res Ther"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"Jha A.K.","year":"2015","unstructured":"Jha A.K.; Huang S.C.C.; Sergushichev A.; Lampropoulou V.; Ivanova Y.; Loginicheva E.; Chmielewski K.; Stewart K.M.; Ashall J.; Everts B.; Pearce E.J.; Driggers E.M.; Artyomov M.N.; Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 2015,42(3),419-430","journal-title":"Immunity"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"Tannahill G.M.","year":"2013","unstructured":"Tannahill G.M.; Curtis A.M.; Adamik J.; Palsson-McDermott E.M.; McGettrick A.F.; Goel G.; Frezza C.; Bernard N.J.; Kelly B.; Foley N.H.; Zheng L.; Gardet A.; Tong Z.; Jany S.S.; Corr S.C.; Haneklaus M.; Caffrey B.E.; Pierce K.; Walmsley S.; Beasley F.C.; Cummins E.; Nizet V.; Whyte M.; Taylor C.T.; Lin H.; Masters S.L.; Gottlieb E.; Kelly V.P.; Clish C.; Auron P.E.; Xavier R.J.; O\u2019Neill L.A.J.; Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 2013,496(7444),238-242","journal-title":"Nature"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"6550","DOI":"10.1096\/fj.201800285","volume":"32","author":"Saraiva A.L.","year":"2018","unstructured":"Saraiva A.L.; Veras F.P.; Peres R.S.; Talbot J.; Lima K.A.; Luiz J.P.; Carballido J.M.; Cunha T.M.; Cunha F.Q.; Ryffel B.; Alves-Filho J.C.; Succinate receptor deficiency attenuates arthritis by reducing dendritic cell traffic and expansion of T 17 cells in the lymph nodes. FASEB J 2018,32(12),6550-6558","journal-title":"FASEB J"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20160061","volume":"213","author":"Littlewood-Evans A.","year":"2016","unstructured":"Littlewood-Evans A.; Sarret S.; Apfel V.; Loesle P.; Dawson J.; Zhang J.; Muller A.; Tigani B.; Kneuer R.; Patel S.; Valeaux S.; Gommermann N.; Rubic-Schneider T.; Junt T.; Carballido J.M.; GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J Exp Med 2016,213(9),1655-1662","journal-title":"J Exp Med"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2018.07.009","volume":"126","author":"Li Y.","year":"2018","unstructured":"Li Y.; Liu Y.; Wang C.; Xia W.R.; Zheng J.Y.; Yang J.; Liu B.; Liu J.Q.; Liu L.F.; Succinate induces synovial angiogenesis in rheumatoid arthritis through metabolic remodeling and HIF-1\u03b1\/VEGF axis. Free Radic Biol Med 2018,126,1-14","journal-title":"Free Radic Biol Med"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature25986","volume":"556","author":"Mills E.L.","year":"2018","unstructured":"Mills E.L.; Ryan D.G.; Prag H.A.; Dikovskaya D.; Menon D.; Zaslona Z.; Jedrychowski M.P.; Costa A.S.H.; Higgins M.; Hams E.; Szpyt J.; Runtsch M.C.; King M.S.; McGouran J.F.; Fischer R.; Kessler B.M.; McGettrick A.F.; Hughes M.M.; Carroll R.G.; Booty L.M.; Knatko E.V.; Meakin P.J.; Ashford M.L.J.; Modis L.K.; Brunori G.; S\u00e9vin D.C.; Fallon P.G.; Caldwell S.T.; Kunji E.R.S.; Chouchani E.T.; Frezza C.; Dinkova-Kostova A.T.; Hartley R.C.; Murphy M.P.; O\u2019Neill L.A.; Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 2018,556(7699),113-117","journal-title":"Nature"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"31159","DOI":"10.1038\/srep31159","volume":"6","author":"McGuire V.A.","year":"2016","unstructured":"McGuire V.A.; Ruiz-Zorrilla Diez T.; Emmerich C.H.; Strickson S.; Ritorto M.S.; Sutavani R.V.; Wei\u03b2 A.; Houslay K.F.; Knebel A.; Meakin P.J.; Phair I.R.; Ashford M.L.J.; Trost M.; Arthur J.S.C.; Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation. Sci Rep 2016,6(1),31159","journal-title":"Sci Rep"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJMoa1114287","volume":"367","author":"Gold R.","year":"2012","unstructured":"Gold R.; Kappos L.; Arnold D.L.; Bar-Or A.; Giovannoni G.; Selmaj K.; Tornatore C.; Sweetser M.T.; Yang M.; Sheikh S.I.; Dawson K.T.; Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med 2012,367(12),1098-1107","journal-title":"N Engl J Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"Fox R.J.","year":"2012","unstructured":"Fox R.J.; Miller D.H.; Phillips J.T.; Hutchinson M.; Havrdova E.; Kita M.; Yang M.; Raghupathi K.; Novas M.; Sweetser M.T.; Viglietta V.; Dawson K.T.; Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012,367(12),1087-1097","journal-title":"N Engl J Med"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/jcmm.13367","volume":"22","author":"Yamaguchi Y.","year":"2018","unstructured":"Yamaguchi Y.; Kanzaki H.; Katsumata Y.; Itohiya K.; Fukaya S.; Miyamoto Y.; Narimiya T.; Wada S.; Nakamura Y.; Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation. J Cell Mol Med 2018,22(2),1138-1147","journal-title":"J Cell Mol Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/art.1780090106","volume":"9","author":"Cummings N.A.","year":"1966","unstructured":"Cummings N.A.; Nordby G.L.; Measurement of synovial fluid pH in normal and arthritic knees. Arthritis Rheum 1966,9(1),47-56","journal-title":"Arthritis Rheum"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1136\/annrheumdis-2012-202352","volume":"72","author":"Croia C.","year":"2013","unstructured":"Croia C.; Serafini B.; Bombardieri M.; Kelly S.; Humby F.; Severa M.; Rizzo F.; Coccia E.M.; Migliorini P.; Aloisi F.; Pitzalis C.; Epstein\u2013Barr virus persistence and infection of autoreactive plasma cells in synovial lymphoid structures in rheumatoid arthritis. Ann Rheum Dis 2013,72(9),1559-1568","journal-title":"Ann Rheum Dis"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/eji.201646477","volume":"47","author":"Pucino V.","year":"2017","unstructured":"Pucino V.; Bombardieri M.; Pitzalis C.; Mauro C.; Lactate at the crossroads of metabolism, inflammation, and autoimmunity. Eur J Immunol 2017,47(1),14-21","journal-title":"Eur J Immunol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"e1002202","DOI":"10.1371\/journal.pbio.1002202","volume":"13","author":"Haas R.","year":"2015","unstructured":"Haas R.; Smith J.; Rocher-Ros V.; Nadkarni S.; Montero-Melendez T.; D\u2019Acquisto F.; Bland E.J.; Bombardieri M.; Pitzalis C.; Perretti M.; Marelli-Berg F.M.; Mauro C.; Lactate regulates metabolic and pro-inflammatory circuits in control of T cell migration and effector functions. PLoS Biol 2015,13(7),e1002202","journal-title":"PLoS Biol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1172\/JCI84431","volume":"126","author":"Corcoran S.E.","year":"2016","unstructured":"Corcoran S.E.; O\u2019Neill L.A.J.; HIF1\u03b1 and metabolic reprogramming in inflammation. J Clin Invest 2016,126(10),3699-3707","journal-title":"J Clin Invest"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"Kelly B.","year":"2015","unstructured":"Kelly B.; O\u2019Neill L.A.J.; Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res 2015,25(7),771-784","journal-title":"Cell Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1749-6632.2009.05039.x","volume":"1177","author":"Weinberg F.","year":"2009","unstructured":"Weinberg F.; Chandel N.S.; Mitochondrial metabolism and cancer. Ann N Y Acad Sci 2009,1177(1),66-73","journal-title":"Ann N Y Acad Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"e97501","DOI":"10.1371\/journal.pone.0097501","volume":"9","author":"Kim S.","year":"2014","unstructured":"Kim S.; Hwang J.; Xuan J.; Jung Y.H.; Cha H.S.; Kim K.H.; Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLoS One 2014,9(6),e97501","journal-title":"PLoS One"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cellsig.2014.03.030","volume":"26","author":"Salminen A.","year":"2014","unstructured":"Salminen A.; Kaarniranta K.; Hiltunen M.; Kauppinen A.; Krebs cycle dysfunction shapes epigenetic landscape of chromatin: Novel insights into mitochondrial regulation of aging process. Cell Signal 2014,26(7),1598-1603","journal-title":"Cell Signal"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1146\/annurev-physiol-021115-105403","volume":"78","author":"Peti-Peterdi J.","year":"2016","unstructured":"Peti-Peterdi J.; Kishore B.K.; Pluznick J.L.; Regulation of vascular and renal function by metabolite receptors. Annu Rev Physiol 2016,78(1),391-414","journal-title":"Annu Rev Physiol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","volume":"24","author":"Mills E.","year":"2014","unstructured":"Mills E.; O\u2019Neill L.A.J.; Succinate: A metabolic signal in inflammation. Trends Cell Biol 2014,24(5),313-320","journal-title":"Trends Cell Biol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.smim.2015.09.001","volume":"27","author":"Kasmi K.C.E.","year":"2015","unstructured":"Kasmi K.C.E.; Stenmark K.R.; Contribution of metabolic reprogramming to macrophage plasticity and function. Seminars in immunology Semin Immunol 2015,27(4),267-75","journal-title":"Seminars in immunology Semin Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbabio.2016.03.012","volume":"1857","author":"Tretter L.","year":"2016","unstructured":"Tretter L.; Patocs A.; Chinopoulos C.; Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis. Biochim Biophys Acta Bioenerg 2016,1857(8),1086-1101","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/eji.201445427","volume":"46","author":"Mills E.L.","year":"2016","unstructured":"Mills E.L.; O\u2019Neill L.A.; Reprogramming mitochondrial metabolism in macrophages as an anti-inflammatory signal. Eur J Immunol 2016,46(1),13-21","journal-title":"Eur J Immunol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/annrheumdis-2013-203670","volume":"74","author":"Bonnet C.S.","year":"2015","unstructured":"Bonnet C.S.; Williams A.S.; Gilbert S.J.; Harvey A.K.; Evans B.A.; Mason D.J.; AMPA\/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis. Ann Rheum Dis 2015,74(1),242-251","journal-title":"Ann Rheum Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"R844","DOI":"10.1186\/ar1752","volume":"7","author":"Da Sylva T.R.","year":"2005","unstructured":"Da Sylva T.R.; Connor A.; Mburu Y.; Keystone E.; Wu G.E.; Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes. Arthritis Res 2005,7(4),R844-R851","journal-title":"Arthritis Res"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/annrheumdis-2011-200245","volume":"71","author":"Harty L.C.","year":"2012","unstructured":"Harty L.C.; Biniecka M.; O\u2019Sullivan J.; Fox E.; Mulhall K.; Veale D.J.; Fearon U.; Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis. Ann Rheum Dis 2012,71(4),582-588","journal-title":"Ann Rheum Dis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10067-014-2597-z","volume":"33","author":"Datta S.","year":"2014","unstructured":"Datta S.; Kundu S.; Ghosh P.; De S.; Ghosh A.; Chatterjee M.; Correlation of oxidant status with oxidative tissue damage in patients with rheumatoid arthritis. Clin Rheumatol 2014,33(11),1557-1564","journal-title":"Clin Rheumatol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.2174\/13816128113199990507","volume":"19","author":"Ishibashi T.","year":"2013","unstructured":"Ishibashi T.; Molecular hydrogen: New antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases. Curr Pharm Des 2013,19(35),6375-6381","journal-title":"Curr Pharm Des"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"e1887","DOI":"10.1038\/cddis.2015.246","volume":"6","author":"Chimenti M","year":"2015","unstructured":"Chimenti M; Triggianese P; Conigliaro P; Candi E; Melino G; Perricone R; The interplay between inflammation and metabolism in rheumatoid arthritis. Cell Death Disease 2015,6(9),e1887","journal-title":"Cell Death Disease"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1182\/blood-2004-09-3662","volume":"106","author":"Lee N.K.","year":"2005","unstructured":"Lee N.K.; Choi Y.G.; Baik J.Y.; Han S.Y.; Jeong D.; Bae Y.S.; Kim N.; Lee S.Y.; A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 2005,106(3),852-859","journal-title":"Blood"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"9","DOI":"10.15698\/cst2020.01.209","volume":"4","author":"Cucchi D.","year":"2020","unstructured":"Cucchi D.; Camacho-Mu\u00f1oz D.; Certo M.; Pucino V.; Nicolaou A.; Mauro C.; Fatty acids \u2013 from energy substrates to key regulators of cell survival, proliferation and effector function. Cell Stress 2020,4(1),9-23","journal-title":"Cell Stress"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/13543784.2019.1555237","volume":"28","author":"Marone G.","year":"2019","unstructured":"Marone G.; Galdiero M.R.; Pecoraro A.; Pucino V.; Criscuolo G.; Triassi M.; Varricchi G.; Prostaglandin D receptor antagonists in allergic disorders: Safety, efficacy, and future perspectives. Expert Opin Investig Drugs 2019,28(1),73-84","journal-title":"Expert Opin Investig Drugs"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nature11132","volume":"486","author":"Cipolletta D.","year":"2012","unstructured":"Cipolletta D.; Feuerer M.; Li A.; Kamei N.; Lee J.; Shoelson S.E.; Benoist C.; Mathis D.; PPAR-\u03b3 is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012,486(7404),549-553","journal-title":"Nature"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1084\/jem.20082771","volume":"206","author":"Klotz L.","year":"2009","unstructured":"Klotz L.; Burgdorf S.; Dani I.; Saijo K.; Flossdorf J.; Hucke S.; Alferink J.; Novak N.; Beyer M.; Mayer G.; Langhans B.; Klockgether T.; Waisman A.; Eberl G.; Schultze J.; Famulok M.; Kolanus W.; Glass C.; Kurts C.; Knolle P.A.; The nuclear receptor PPAR\u03b3 selectively inhibits Th17 differentiation in a T cell\u2013intrinsic fashion and suppresses CNS autoimmunity. J Exp Med 2009,206(10),2079-2089","journal-title":"J Exp Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.med.53.082901.104018","volume":"53","author":"Berger J.","year":"2002","unstructured":"Berger J.; Moller D.E.; The mechanisms of action of PPARs. Annu Rev Med 2002,53(1),409-435","journal-title":"Annu Rev Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"Park J.","year":"2015","unstructured":"Park J.; Kim M.; Kang S.G.; Jannasch A.H.; Cooper B.; Patterson J.; Kim C.H.; Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR\u2013S6K pathway. Mucosal Immunol 2015,8(1),80-93","journal-title":"Mucosal Immunol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/ni.2570","volume":"14","author":"Kidani Y.","year":"2013","unstructured":"Kidani Y.; Elsaesser H.; Hock M.B.; Vergnes L.; Williams K.J.; Argus J.P.; Marbois B.N.; Komisopoulou E.; Wilson E.B.; Osborne T.F.; Graeber T.G.; Reue K.; Brooks D.G.; Bensinger S.J.; Sterol regulatory element\u2013binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat Immunol 2013,14(5),489-499","journal-title":"Nat Immunol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3808","volume":"18","author":"Shen Y.","year":"2017","unstructured":"Shen Y.; Wen Z.; Li Y.; Matteson E.L.; Hong J.; Goronzy J.J.; Weyand C.M.; Metabolic control of the scaffold protein TKS5 in tissue-invasive, proinflammatory T cells. Nat Immunol 2017,18(9),1025-1034","journal-title":"Nat Immunol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"Berod L.","year":"2014","unstructured":"Berod L.; Friedrich C.; Nandan A.; Freitag J.; Hagemann S.; Harmrolfs K.; Sandouk A.; Hesse C.; Castro C.N.; B\u00e4hre H.; Tschirner S.K.; Gorinski N.; Gohmert M.; Mayer C.T.; Huehn J.; Ponimaskin E.; Abraham W.R.; M\u00fcller R.; Lochner M.; Sparwasser T.; De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat Med 2014,20(11),1327-1333","journal-title":"Nat Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-019-08332-9","volume":"10","author":"Perucha E.","year":"2019","unstructured":"Perucha E.; Melchiotti R.; Bibby J.A.; Wu W.; Frederiksen K.S.; Roberts C.A.; Hall Z.; LeFriec G.; Robertson K.A.; Lavender P.; Gerwien J.G.; Taams L.S.; Griffin J.L.; de Rinaldis E.; van Baarsen L.G.M.; Kemper C.; Ghazal P.; Cope A.P.; The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells. Nat Commun 2019,10(1),498","journal-title":"Nat Commun"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/03009742.2016.1164242","volume":"46","author":"Volchenkov R.","year":"2017","unstructured":"Volchenkov R.; Dung Cao M.; Elgst\u00f8en K.B.; Goll G.L.; Eikvar K.; Bj\u00f8rneboe O.; Bathen T.F.; Holen H.L.; Kvien T.K.; Sk\u00e5lhegg B.S.; Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples. Scand J Rheumatol 2017,46(2),160-161","journal-title":"Scand J Rheumatol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jbspin.2015.11.009","volume":"83","author":"Ahn J.K.","year":"2016","unstructured":"Ahn J.K.; Kim S.; Hwang J.; Kim J.; Kim K.H.; Cha H.S.; GC\/TOF-MS-based metabolomic profiling in cultured fibroblast-like synoviocytes from rheumatoid arthritis. Joint Bone Spine 2016,83(6),707-713","journal-title":"Joint Bone Spine"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/14397595.2017.1280118","volume":"27","author":"Seki M.","year":"2017","unstructured":"Seki M.; Kawai Y.; Ishii C.; Yamanaka T.; Odawara M.; Inazu M.; Functional analysis of choline transporters in rheumatoid arthritis synovial fibroblasts. Mod Rheumatol 2017,27(6),995-1003","journal-title":"Mod Rheumatol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.3390\/nu11112623","volume":"11","author":"Rose A.J.","year":"2019","unstructured":"Rose A.J.; Amino acid nutrition and metabolism in health and disease. Nutrients 2019,11(11),2623","journal-title":"Nutrients"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ni.3323","volume":"17","author":"Murray P.J.","year":"2016","unstructured":"Murray P.J.; Amino acid auxotrophy as a system of immunological control nodes. Nat Immunol 2016,17(2),132-139","journal-title":"Nat Immunol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1385\/IR:22:1:1","volume":"22","author":"Singh V.K.","year":"2000","unstructured":"Singh V.K.; Mehrotra S.; Narayan P.; Pandey C.M.; Agarwal S.S.; Modulation of autoimmune diseases by nitric oxide. Immunol Res 2000,22(1),1-20","journal-title":"Immunol Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s10067-005-0056-6","volume":"25","author":"Schroecksnadel K.","year":"2006","unstructured":"Schroecksnadel K.; Winkler C.; Duftner C.; Wirleitner B.; Schirmer M.; Fuchs D.; Tryptophan degradation increases with stage in patients with rheumatoid arthritis. Clin Rheumatol 2006,25(3),334-337","journal-title":"Clin Rheumatol"},{"key":"ref=103","first-page":"287","volume":"527","author":"Forrest C.M.","year":"2003","unstructured":"Forrest C.M.; Kennedy A.; Stone T.W.; Stoy N.; Darlington L.G.; Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment. Allegri, G, Costa, CVL, Ragazzi, E, Steinhart, H, Varesio, L Eds, Developments in tryptophan and serotonin metabolism Advances in experimental medicine and biology 2003,527,287-295","journal-title":"Allegri, G, Costa, CVL, Ragazzi, E, Steinhart, H, Varesio, L Eds, Developments in tryptophan and serotonin metabolism Advances in experimental medicine and biology"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1002\/art.38715","volume":"66","author":"Cribbs A.P.","year":"2014","unstructured":"Cribbs A.P.; Kennedy A.; Penn H.; Read J.E.; Amjadi P.; Green P.; Syed K.; Manka S.W.; Brennan F.M.; Gregory B.; Williams R.O.; Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway. Arthritis Rheumatol 2014,66(9),2344-2354","journal-title":"Arthritis Rheumatol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/art.24446","volume":"60","author":"Criado G.","year":"2009","unstructured":"Criado G.; \u0160imelyte E.; Inglis J.J.; Essex D.; Williams R.O.; Indoleamine 2,3 dioxygenase-mediated tryptophan catabolism regulates accumulation of Th1\/Th17 cells in the joint in collagen-induced arthritis. Arthritis Rheum 2009,60(5),1342-1351","journal-title":"Arthritis Rheum"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1089\/hum.2009.217","volume":"22","author":"Chen S.Y.","year":"2011","unstructured":"Chen S.Y.; Wu C.L.; Lai M.D.; Lin C.C.; Yo Y.T.; Jou I.M.; Lee C.H.; Weng C.T.; Shiau A.L.; Wang C.R.; Amelioration of rat collagen-induced arthritis through CD4+ T cells apoptosis and synovial interleukin-17 reduction by indoleamine 2,3-dioxygenase gene therapy. Hum Gene Ther 2011,22(2),145-154","journal-title":"Hum Gene Ther"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.4049\/jimmunol.1502125","volume":"197","author":"Chalise J.P.","year":"2016","unstructured":"Chalise J.P.; Pallotta M.T.; Narendra S.C.; Carlsson B.; Iacono A.; Namale J.; Boon L.; Grohmann U.; Magnusson M.; IDO1 and TGF-\u03b2 mediate protective effects of IFN-\u03b1 in antigen-induced arthritis. J Immunol 2016,197(8),3142-3151","journal-title":"J Immunol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.4049\/jimmunol.1303012","volume":"192","author":"Merlo L.M.F.","year":"2014","unstructured":"Merlo L.M.F.; Pigott E.; DuHadaway J.B.; Grabler S.; Metz R.; Prendergast G.C.; Mandik-Nayak L.; IDO is a critical mediator of autoantibody production and inflammatory pathogenesis in a mouse model of autoimmune arthritis. J Immunol 2014,192(5),2082-2090","journal-title":"J Immunol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrrheum.2017.33","volume":"13","author":"Collison J.","year":"2017","unstructured":"Collison J.; Do you want to treat arthritis? IDO! Nat Rev Rheumatol 2017,13(4),197","journal-title":"Nat Rev Rheumatol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clim.2017.01.016","volume":"179","author":"Merlo L.M.F.","year":"2017","unstructured":"Merlo L.M.F.; Grabler S.; DuHadaway J.B.; Pigott E.; Manley K.; Prendergast G.C.; Laury-Kleintop L.D.; Mandik-Nayak L.; Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO) inhibits autoimmune arthritis. Clin Immunol 2017,179,8-16","journal-title":"Clin Immunol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13075-018-1616-x","volume":"20","author":"Chandrasekharan U.M.","year":"2018","unstructured":"Chandrasekharan U.M.; Wang Z.; Wu Y.; Wilson Tang W.H.; Hazen S.L.; Wang S.; Husni M.E.; Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis. Arthritis Res Ther 2018,20(1),123","journal-title":"Arthritis Res Ther"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.4049\/jimmunol.1601330","volume":"198","author":"Hannemann N.","year":"2017","unstructured":"Hannemann N.; Jordan J.; Paul S.; Reid S.; Baenkler H.W.; Sonnewald S.; B\u00e4uerle T.; Vera J.; Schett G.; Bozec A.; The AP-1 transcription factor c-Jun promotes arthritis by regulating cyclooxygenase-2 and arginase-1 expression in macrophages. J Immunol 2017,198(9),3605-3614","journal-title":"J Immunol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.1038\/ncomms11596","volume":"7","author":"Chen Z.","year":"2016","unstructured":"Chen Z.; Andreev D.; Oeser K.; Krljanac B.; Hueber A.; Kleyer A.; Voehringer D.; Schett G.; Bozec A.; Th2 and eosinophil responses suppress inflammatory arthritis. Nat Commun 2016,7(1),11596","journal-title":"Nat Commun"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fphys.2020.00347","volume":"11","author":"Pucino V.","year":"2020","unstructured":"Pucino V.; Certo M.; Varricchi G.; Marone G.; Ursini F.; Rossi F.W.; De Paulis A.; Mauro C.; Raza K.; Buckley C.D.; Metabolic checkpoints in rheumatoid arthritis. Front Physiol 2020,11,347","journal-title":"Front Physiol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2741\/4218","volume":"19","author":"Shirwany N.","year":"2014","unstructured":"Shirwany N.; Zou M-H.; AMPK: A cellular metabolic and redox sensor. A minireview. Front Biosci 2014,19(3),447-474","journal-title":"Front Biosci"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1136\/annrheumdis-2014-206305","volume":"75","author":"Thornton C.C.","year":"2016","unstructured":"Thornton C.C.; Al-Rashed F.; Calay D.; Birdsey G.M.; Bauer A.; Mylroie H.; Morley B.J.; Randi A.M.; Haskard D.O.; Boyle J.J.; Mason J.C.; Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: A novel mechanism for vascular protection in chronic systemic inflammation. Ann Rheum Dis 2016,75(2),439-448","journal-title":"Ann Rheum Dis"},{"key":"ref=117","first-page":"5","volume":"1","author":"Yan H","year":"2015","unstructured":"Yan H; Zhou H-f; Hu Y; Pham CT.; Suppression of experimental arthritis through AMP-activated protein kinase activation and autophagy modulation. J Rheum Dis 2015,1(1),5","journal-title":"J Rheum Dis"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.intimp.2013.03.020","volume":"16","author":"Kang K.Y.","year":"2013","unstructured":"Kang K.Y.; Kim Y.K.; Yi H.; Kim J.; Jung H.R.; Kim I.J.; Cho J.H.; Park S.H.; Kim H.Y.; Ju J.H.; Metformin downregulates Th17 cells differentiation and attenuates murine autoimmune arthritis. Int Immunopharmacol 2013,16(1),85-92","journal-title":"Int Immunopharmacol"},{"key":"ref=119","first-page":"973986","volume":"2014","author":"Son H-J","year":"2014","unstructured":"Son H-J; Lee J; Lee S-Y; Kim E-K; Park M-J; Kim K-W.; Metformin attenuates experimental autoimmune arthritis through reciprocal regulation of Th17\/Treg balance and osteoclastogenesis. Mediat Inflamm 2014,2014,973986","journal-title":"Mediat Inflamm"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1189\/jlb.3A0915-399R","volume":"99","author":"Pucino V.","year":"2016","unstructured":"Pucino V.; Lucherini O.M.; Perna F.; Obici L.; Merlini G.; Cattalini M.; La Torre F.; Maggio M.C.; Lepore M.T.; Magnotti F.; Galgani M.; Galeazzi M.; Marone G.; De Rosa V.; Talarico R.; Cantarini L.; Matarese G.; Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4 T cell functions in TNFR1-associated periodic syndrome. J Leukoc Biol 2016,99(5),761-769","journal-title":"J Leukoc Biol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.it.2014.11.005","volume":"36","author":"Pollizzi K.N.","year":"2015","unstructured":"Pollizzi K.N.; Powell J.D.; Regulation of T cells by mTOR: The known knowns and the known unknowns. Trends Immunol 2015,36(1),13-20","journal-title":"Trends Immunol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.molimm.2015.07.026","volume":"68","author":"Delgoffe G.M.","year":"2015","unstructured":"Delgoffe G.M.; Powell J.D.; Feeding an army: The metabolism of T cells in activation, anergy, and exhaustion. Mol Immunol 2015,68(2),492-496","journal-title":"Mol Immunol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"Perl A.","year":"2016","unstructured":"Perl A.; Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol 2016,12(3),169-182","journal-title":"Nat Rev Rheumatol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/ard.62.2.133","volume":"62","author":"Kuhnke A.","year":"2003","unstructured":"Kuhnke A.; Burmester G.R.; Krauss S.; Buttgereit F.; Bioenergetics of immune cells to assess rheumatic disease activity and efficacy of glucocorticoid treatment. Ann Rheum Dis 2003,62(2),133-139","journal-title":"Ann Rheum Dis"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0167-4889(91)90227-O","volume":"1091","author":"Moreno-Aurioles V.R.","year":"1991","unstructured":"Moreno-Aurioles V.R.; Sobrino F.; Glucocorticoids inhibit fructose 2,6-bisphosphate synthesis in rat thymocytes. Opposite effect of cycloheximide. Biochim Biophys Acta Mol Cell Res 1991,1091(1),96-100","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"Cronstein B.N.","year":"2020","unstructured":"Cronstein B.N.; Aune T.M.; Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 2020,16(3),145-154","journal-title":"Nat Rev Rheumatol"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1002\/art.40569","volume":"70","author":"McGarry T.","year":"2018","unstructured":"McGarry T.; Orr C.; Wade S.; Biniecka M.; Wade S.; Gallagher L.; Low C.; Veale D.J.; Fearon U.; JAK\/STAT blockade alters synovial bioenergetics, mitochondrial function, and proinflammatory mediators in rheumatoid arthritis. Arthritis Rheumatol 2018,70(12),1959-1970","journal-title":"Arthritis Rheumatol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.trsl.2016.12.003","volume":"183","author":"Ruiz-Lim\u00f3n P.","year":"2017","unstructured":"Ruiz-Lim\u00f3n P.; Ortega R.; Arias de la Rosa I.; Abalos-Aguilera M.C.; Perez- Sanchez C.; Jimenez- Gomez Y.; Peralbo-Santaella E.; Font P.; Ruiz-Vilches D.; Ferrin G.; Collantes-Estevez E.; Escudero-Contreras A.; L\u00f3pez- Pedrera C.; Barbarroja N.; Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation. Transl Res 2017,183,87-103","journal-title":"Transl Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.18632\/oncotarget.23425","volume":"9","author":"Gu J.J.","year":"2018","unstructured":"Gu J.J.; Singh A.; Xue K.; Mavis C.; Barth M.; Yanamadala V.; Lenz P.; Grau M.; Lenz G.; Czuczman M.S.; Hernandez-Ilizaliturri F.J.; Up-regulation of hexokinase II contributes to rituximab-chemotherapy resistance and is a clinically relevant target for therapeutic development. Oncotarget 2018,9(3),4020-4033","journal-title":"Oncotarget"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.autrev.2019.02.004","volume":"18","author":"Mondanelli G.","year":"2019","unstructured":"Mondanelli G.; Iacono A.; Carvalho A.; Orabona C.; Volpi C.; Pallotta M.T.; Matino D.; Esposito S.; Grohmann U.; Amino acid metabolism as drug target in autoimmune diseases. Autoimmun Rev 2019,18(4),334-348","journal-title":"Autoimmun Rev"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3831\/KPI.2019.22.029","volume":"22","author":"Kesharwani D.","year":"2019","unstructured":"Kesharwani D.; Paliwal R.; Satapathy T.; Paul S.D.; Rheumatiod arthritis: An updated overview of latest therapy and drug delivery. J Pharmacopuncture 2019,22(4),210-224","journal-title":"J Pharmacopuncture"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"e712","DOI":"10.1016\/S2665-9913(20)30344-1","volume":"2","author":"Nel H.J.","year":"2020","unstructured":"Nel H.J.; Malmstr\u00f6m V.; Wraith D.C.; Thomas R.; Autoantigens in rheumatoid arthritis and the potential for antigen-specific tolerising immunotherapy. Lancet Rheumatol 2020,2(11),e712-e723","journal-title":"Lancet Rheumatol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4110\/in.2016.16.1.44","volume":"16","author":"Ahmed M.S.","year":"2016","unstructured":"Ahmed M.S.; Bae Y.S.; Dendritic cell-based immunotherapy for rheumatoid arthritis: From bench to bedside. Immune Netw 2016,16(1),44-51","journal-title":"Immune Netw"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2018-213103","volume":"77","author":"Bustamante M.F.","year":"2018","unstructured":"Bustamante M.F.; Oliveira P.G.; Garcia-Carbonell R.; Croft A.P.; Smith J.M.; Serrano R.L.; Sanchez-Lopez E.; Liu X.; Kisseleva T.; Hay N.; Buckley C.D.; Firestein G.S.; Murphy A.N.; Miyamoto S.; Guma M.; Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis. Ann Rheum Dis 2018,77(11),1636-1643","journal-title":"Ann Rheum Dis"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1002\/wsbm.1474","volume":"12","author":"Certo M.","year":"2020","unstructured":"Certo M.; Marone G.; Paulis A.; Mauro C.; Pucino V.; Lactate: Fueling the fire starter. Wiley Interdiscip Rev Syst Biol Med 2020,12(3),e1474","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1080\/14728222.2018.1511706","volume":"22","author":"Pucino V.","year":"2018","unstructured":"Pucino V.; Cucchi D.; Mauro C.; Lactate transporters as therapeutic targets in cancer and inflammatory diseases. Expert Opin Ther Targets 2018,22(9),735-743","journal-title":"Expert Opin Ther Targets"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bcp.2018.10.033","volume":"158","author":"Albini E.","year":"2018","unstructured":"Albini E.; Coletti A.; Greco F.; Pallotta M.T.; Mondanelli G.; Gargaro M.; Belladonna M.L.; Volpi C.; Bianchi R.; Grohmann U.; Macchiarulo A.; Orabona C.; Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1. Biochem Pharmacol 2018,158,286-297","journal-title":"Biochem Pharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/art.27503","volume":"62","author":"Bevaart L.","year":"2010","unstructured":"Bevaart L.; Vervoordeldonk M.J.; Tak P.P.; Evaluation of therapeutic targets in animal models of arthritis: How does it relate to rheumatoid arthritis? Arthritis Rheum 2010,62(8),2192-2205","journal-title":"Arthritis Rheum"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/ard.2007.076430","volume":"67","author":"Hegen M.","year":"2008","unstructured":"Hegen M.; Keith J.C.; Collins M.; Nickerson-Nutter C.L.; Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis 2008,67(11),1505-1515","journal-title":"Ann Rheum Dis"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1741-7015-7-12","volume":"7","author":"van Vollenhoven R.F.","year":"2009","unstructured":"van Vollenhoven R.F.; Sex differences in rheumatoid arthritis: More than meets the eye. BMC Med 2009,7(1),12","journal-title":"BMC Med"},{"key":"ref=141","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/rheumatology\/kex239","volume":"56","author":"Alp\u00edzar-Rodr\u00edguez D.","year":"2017","unstructured":"Alp\u00edzar-Rodr\u00edguez D.; Pluchino N.; Canny G.; Gabay C.; Finckh A.; The role of female hormonal factors in the development of rheumatoid arthritis. Rheumatology 2017,56(8),1254-1263","journal-title":"Rheumatology"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"101435","DOI":"10.1016\/j.redox.2020.101435","volume":"31","author":"Klinge C.M.","year":"2020","unstructured":"Klinge C.M.; Estrogenic control of mitochondrial function. Redox Biol 2020,31,101435","journal-title":"Redox Biol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/onc.2012.221","volume":"32","author":"Cai Q.","year":"2013","unstructured":"Cai Q.; Lin T.; Kamarajugadda S.; Lu J.; Regulation of glycolysis and the Warburg effect by estrogen-related receptors. Oncogene 2013,32(16),2079-2086","journal-title":"Oncogene"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1039\/C8LC01239C","volume":"19","author":"Salomon R.","year":"2019","unstructured":"Salomon R.; Kaczorowski D.; Valdes-Mora F.; Nordon R.E.; Neild A.; Farbehi N.; Bartonicek N.; Gallego-Ortega D.; Droplet-based single cell RNAseq tools: A practical guide. Lab Chip 2019,19(10),1706-1727","journal-title":"Lab Chip"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220907151213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208618\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220907151213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T19:42:03Z","timestamp":1701027723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208618\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":144,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220907151213","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-24","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}